Insights

Open Access Leadership BioMed Central's pioneering role in open access research publishing offers opportunities for collaboration with organizations seeking to enhance dissemination and visibility of their scientific outputs through custom publishing solutions or platform integrations.

Research & Innovation Focus With recent initiatives in healthcare, cancer therapy, and renewable energy, BioMed Central demonstrates a strong commitment to research-driven projects, presenting potential for partnerships in grant-funded technology development, clinical trials, and innovative health solutions.

Technology Infrastructure Utilizing advanced tech stacks such as Google BigQuery and Oracle underscores BioMed Central's capacity for data-driven publishing and research analytics, indicating demand for cloud computing, data management, and AI services to support their digital publishing ecosystem.

Strategic Collaborations Partnerships with UNESCO, government agencies, and NGOs highlight BioMed Central's active engagement in global health and education initiatives, creating opportunities for software solutions, health tech platforms, and project management tools tailored to multi-stakeholder environments.

Market & Growth Potential With revenues in the range of fifty to one hundred million dollars and a diverse portfolio of specialized journals, BioMed Central is positioned for expansion in the health research sector, offering prospects for subscription management, content monetization, and institutional licensing services.

BioMed Central Tech Stack

BioMed Central uses 8 technology products and services including Fastly, Cloudflare CDN, Open Graph, and more. Explore BioMed Central's tech stack below.

  • Fastly
    Content Delivery Network
  • Cloudflare CDN
    Content Delivery Network
  • Open Graph
    Content Management System
  • Babel
    Development
  • Oracle
    Enterprise
  • SoundManager
    Javascript Libraries
  • LinkedIn
    Online Community Software
  • Google
    Search Engines

Media & News

BioMed Central's Email Address Formats

BioMed Central uses at least 1 format(s):
BioMed Central Email FormatsExamplePercentage
First.Last@biomedcentral.comJohn.Doe@biomedcentral.com
72%
FirstLast@biomedcentral.comJohnDoe@biomedcentral.com
12%
FirLast@biomedcentral.comJohDoe@biomedcentral.com
10%
First@biomedcentral.comJohn@biomedcentral.com
6%

Frequently Asked Questions

Where is BioMed Central's headquarters located?

Minus sign iconPlus sign icon
BioMed Central's main headquarters is located at 4 Crinan Street, London, N1 9XW, GB. The company has employees across 6 continents, including EuropeAsiaNorth America.

What is BioMed Central's phone number?

Minus sign iconPlus sign icon
You can contact BioMed Central's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is BioMed Central's stock symbol?

Minus sign iconPlus sign icon
BioMed Central is a publicly traded company; the company's stock symbol is BMCIX.

What is BioMed Central's official website and social media links?

Minus sign iconPlus sign icon
BioMed Central's official website is biomedcentral.com and has social profiles on LinkedIn.

How much revenue does BioMed Central generate?

Minus sign iconPlus sign icon
As of October 2025, BioMed Central's annual revenue is estimated to be $5B.

What is BioMed Central's SIC code NAICS code?

Minus sign iconPlus sign icon
BioMed Central's SIC code is 8221 - Colleges, Universities, and Professional Schools NAICS code is 511 - Publishing Industries (except Internet).

How many employees does BioMed Central have currently?

Minus sign iconPlus sign icon
As of October 2025, BioMed Central has approximately 787 employees across 6 continents, including EuropeAsiaNorth America. Key team members include Chief Executive Officer: B. J.Chief Technology Officer: J. T.Chief Editor: L. L.. Explore BioMed Central's employee directory with LeadIQ.

What industry does BioMed Central belong to?

Minus sign iconPlus sign icon
BioMed Central operates in the Book and Periodical Publishing industry.

What technology does BioMed Central use?

Minus sign iconPlus sign icon
BioMed Central's tech stack includes FastlyCloudflare CDNOpen GraphBabelOracleSoundManagerLinkedInGoogle.

What is BioMed Central's email format?

Minus sign iconPlus sign icon
BioMed Central's email format typically follows the pattern of First.Last@biomedcentral.com. Find more BioMed Central email formats with LeadIQ.

When was BioMed Central founded?

Minus sign iconPlus sign icon
BioMed Central was founded in 1998.

BioMed Central

Book and Periodical PublishingUnited Kingdom501-1000 Employees

BMC is a pioneer of open access publishing. We’re committed to innovation in research publishing to support the needs of our communities and ensure the integrity of the research we publish.

Our leading research journals include selective broad interest titles such as Genome Biology and Genome Medicine, academic journals such as Malaria Journal and Microbiome and the BMC series, 65 inclusive journals focused on the needs of individual research communities. We also partner with leading institutions and societies to publish journals on their behalf. 

BMC also manages the UK primary clinical trial registry ISRCTN (https://www.isrctn.com).

Section iconCompany Overview

Headquarters
4 Crinan Street, London, N1 9XW, GB
Phone number
SIC Code
8221 - Colleges, Universities, and Professional Schools
Stock Symbol
BMCIX
NAICS Code
511 - Publishing Industries (except Internet)
Founded
1998
Employees
501-1000

Section iconFunding & Financials

  • $100M$250M

    BioMed Central's revenue is estimated to be in the range of $100M$250M

Section iconFunding & Financials

  • $100M$250M

    BioMed Central's revenue is estimated to be in the range of $100M$250M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.